Research progress on RNA−binding proteins in breast cancer

Breast cancer is the most common malignancy in women and has a high incidence rate and mortality. Abnormal regulation of gene expression plays an important role in breast cancer occurrence and development. RNA-binding proteins (RBPs) are one kind of the key regulators for gene expression. By interacting with RNA, RBPs are widely involved in RNA cutting, transport, editing, intracellular localization, and translation regulation. RBPs are important during breast cancer occurrence and progression by engaging in many aspects, like proliferation, migration, invasion, and stemness. Therefore, comprehensively understanding the role of RBPs in breast cancer progression can facilitate early diagnosis, timely treatment, and long-term survival and quality of life of breast cancer patients.

• Publication year

  2022

• Venue

  Frontiers in Oncology

• Publication date

  2022-08-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fonc.2022.974523PMID 36059653PMCID 9433872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity

  2022cited by this paper
• Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

  2022cited by this paper
• Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein

  2022cited by this paper
• RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7

  2022cited by this paper
• Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

  2022cited by this paper
• Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1

  2021cited by this paper
• Small molecules with tetrahydroquinoline-containing Povarov scaffolds as inhibitors disrupting the Protein-RNA interaction of LIN28-let-7.

  2021cited by this paper
• Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.

  2021cited by this paper
• Docetaxel-triggered SIDT2/NOX4/JNK/HuR signaling axis is associated with TNF-α-mediated apoptosis of cancer cells.

  2021cited by this paper
• Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein–RNA Interaction of LIN28 and Let-7

  2021cited by this paper
• Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors

  2021cited by this paper
• RNA-binding protein QKI suppresses breast cancer via RASA1/MAPK signaling pathway

  2021cited by this paper
• A Novel Long Non‐Coding RNA lnc030 Maintains Breast Cancer Stem Cell Stemness by Stabilizing SQLE mRNA and Increasing Cholesterol Synthesis

  2020cited by this paper
• Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein

  2020cited by this paper
• Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis

  2020cited by this paper
• Global Approaches in Studying RNA-Binding Protein Interaction Networks.

  2020cited by this paper
• RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer

  2020cited by this paper
• CAIX-Mediated Control of LIN28/let-7 Axis Contributes to Metabolic Adaptation of Breast Cancer Cells to Hypoxia

  2020cited by this paper
• Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer.

  2020cited by this paper
• PCBP2 Posttranscriptional Modifications Induce Breast Cancer Progression via Upregulation of UFD1 and NT5E

  2020cited by this paper
• RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer

  2020cited by this paper
• Profiling of specific long non‐coding RNA signatures identifies ST8SIA6‐AS1 AS a novel target for breast cancer

  2020cited by this paper
• Sam68 Promotes the Progression of Human Breast Cancer through Inducing Activation of EphA3.

  2019cited by this paper
• Expression of Lin28 is correlated with prognosis and expression of HER-2 and steroid receptors in breast cancer

  2019cited by this paper
• Prognostic value of epithelial-mesenchymal transition related genes: SLUG and QKI in breast cancer patients.

  2019cited by this paper
• CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins

  2019cited by this paper
• RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network.

  2018cited by this paper
• [Relationship between expression of RBM38 and distant metastasis and prognosis of breast cancer].

  2018cited by this paper
• Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells

  2018cited by this paper
• RNA-binding protein QKI regulates contact inhibition via Yes-associate protein in ccRCC

  2018cited by this paper
• Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28

  2018cited by this paper
• HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.

  2017cited by this paper
• Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets

  2017cited by this paper
• RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer

  2017cited by this paper
• HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells

  2017cited by this paper
• PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer

  2017cited by this paper
• Sam68 Allows Selective Targeting of Human Cancer Stem Cells.

  2017cited by this paper
• Concise Review: LIN28/let-7 Signaling, a Critical Double-Negative Feedback Loop During Pluripotency, Reprogramming, and Tumorigenicity.

  2017cited by this paper
• Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

  2017cited by this paper
• The expression of RNA-binding protein RBM38 decreased in renal cell carcinoma and represses renal cancer cell proliferation, migration, and invasion

  2017cited by this paper
• Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer

  2017cited by this paper
• H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance

  2017cited by this paper
• The role of c-Myc-RBM38 loop in the growth suppression in breast cancer

  2017cited by this paper
• Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression

  2017cited by this paper
• β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression.

  2016cited by this paper
• Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells

  2016cited by this paper
• A large‐scale analysis of alternative splicing reveals a key role of QKI in lung cancer

  2016cited by this paper
• Sam68/KHDRBS1-dependent NF-κB activation confers radioprotection to the colon epithelium in γ-irradiated mice

  2016cited by this paper
• Sam68/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-κB activation

  2016cited by this paper
• The RNA‐binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth

  2016cited by this paper
• RNA-binding Protein Musashi Homologue 1 Regulates Kidney Fibrosis by Translational Inhibition of p21 and Numb mRNA*

  2016cited by this paper
• The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation.

  2016cited by this paper
• Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma.

  2016cited by this paper
• Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function

  2015cited by this paper
• Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.

  2015cited by this paper
• Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer

  2015cited by this paper
• PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38

  2015cited by this paper
• LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans

  2015cited by this paper
• Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction.

  2015cited by this paper
• Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells

  2015cited by this paper
• The phosphorylation status of VASP at serine 322 can be predictive for aggressiveness of invasive ductal carcinoma

  2015cited by this paper
• RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer

  2014cited by this paper
• The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a.

  2014cited by this paper
• The RNA‐Binding Protein Musashi‐1 Regulates Proteasome Subunit Expression in Breast Cancer‐ and Glioma‐Initiating Cells

  2014cited by this paper
• Post-transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells.

  2014cited by this paper
• QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2

  2014cited by this paper
• Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state

  2014cited by this paper
• The tumor suppressing effects of QKI-5 in prostate cancer

  2014cited by this paper
• Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1

  2014cited by this paper
• Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.

  2012cited by this paper
• LIN28 expression and prognostic value in hepatocellular carcinoma patients who meet the Milan criteria and undergo hepatectomy

  2012cited by this paper
• RBM38 Is a Direct Transcriptional Target of E2F1 that Limits E2F1-Induced Proliferation

  2012cited by this paper
• The RNA-binding protein Sam68 is a multifunctional player in human cancer.

  2011cited by this paper
• Sam68 up‐regulation correlates with, and its down‐regulation inhibits, proliferation and tumourigenicity of breast cancer cells

  2010cited by this paper
• RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer.

  2010cited by this paper
• LIN28 alters cell fate succession and acts independently of the let-7 microRNA during neurogliogenesis in vitro

  2010cited by this paper
• The urokinase receptor as an entertainer of signal transduction.

  2009cited by this paper
• Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA.

  2008cited by this paper
• Diverse molecular functions of Hu proteins

  2008cited by this paper
• Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR.

  2008cited by this paper
• Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

  2008cited by this paper
• Structural basis for the recruitment of profilin–actin complexes during filament elongation by Ena/VASP

  2007cited by this paper
• Protein arginine-methyltransferase-dependent oncogenesis

  2007cited by this paper
• The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells

  2007cited by this paper
• Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR.

  2007cited by this paper
• A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy.

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• Target RNA motif and target mRNAs of the Quaking STAR protein

  2005cited by this paper
• Specificity of the STAR/GSG domain protein Qk1: implications for the regulation of myelination.

  2004cited by this paper
• Identification of a target RNA motif for RNA-binding protein HuR.

  2004cited by this paper
• RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1

  2004cited by this paper
• ATP Potentiates Interleukin-1β-induced MMP-9 Expression in Mesangial Cells via Recruitment of the ELAV Protein HuR*

  2003cited by this paper
• Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites.

  2003cited by this paper
• Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo

  2003cited by this paper
• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  2002cited by this paper
• Nuclear retention of MBP mRNAs in the quaking viable mice.

  2002cited by this paper
• HuR and mRNA stability

  2001cited by this paper
• Structural Basis for Recognition of the Intron Branch Site RNA by Splicing Factor 1

  2001cited by this paper
• Intracellular determinants of picornavirus replication.

  1999cited by this paper
• Translational Inhibition in Vitro of Human Papillomavirus Type 16 L2 mRNA Mediated through Interaction with Heterogenous Ribonucleoprotein K and Poly(rC)-binding Proteins 1 and 2*

  1998cited by this paper

• Regulatory roles of RNA binding proteins in the Hippo pathway

  2025cites this paper
• CELF1 promotes aerobic glycolysis and an aggressive phenotype in ER-positive breast cancer via GLUT1 regulation

  2025cites this paper
• Artificial intelligence-assisted RNA-binding protein signature for prognostic stratification and therapeutic guidance in breast cancer

  2025cites this paper
• Cold-Inducible RNA Binding Protein Impedes Breast Tumor Growth in the PyMT Murine Model for Breast Cancer

  2024cites this paper
• Targeting the "tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy.

  2024cites this paper
• Genome-wide characterization of structure variations in the Xiang pig for genetic resistance to African swine fever

  2024cites this paper
• FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer

  2023cites this paper
• LARP4A and LARP4B in cancer: The new kids on the block.

  2023cites this paper
• Data mining identifies novel RNA-binding proteins involved in colon and rectal carcinomas

  2023cites this paper
• The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4

  2023cites this paper
• PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells

  2023cites this paper
• Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography–Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpre

  2023cites this paper